⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 1, 2024CancersOpen Access

Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series

Syed N. Rahman Victoria H. Kong Michael Jalfon David Hesse Joseph Kim Jonathan L. Wright Adebowale Adeniran Peter A. Humphrey Darryl T. Martin Fady Ghali

View Full Paper

Ask AI

Bookmark

Share

Abstract

Plasmacytoid urothelial carcinoma (PUC) is a rare histologic subtype of urothelial carcinoma of the bladder (BC). Our objective was to characterize treatment patterns and outcomes of PUC in the NCDB and our recent institutional experience.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rahman et al. (2024) studied this question.

synapsesocial.com/papers/68e59d83b6db643587537a56 https://doi.org/10.3390/cancers16173050

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Unveiling a Rare and Aggressive Bladder Tumor: A Case Report of Plasmacytoid Urothelial CarcinomaCase Report · 2026
2Clinicopathological Features of Plasmacytoid Urothelial Carcinoma of the Bladder: Case Report and Review of the Literature2024
3Abstract 7436: Dissecting the spatial architecture of plasmacytoid urothelial carcinoma to inform therapeutic strategiesReview · 2026
4Non-Invasive Papillary Urothelial Carcinoma With “Plasmacytoid” Morphology: A Retrospective Review of 500 Consecutive SpecimensCohort Study · 2026
5Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profileCross-Sectional Study · 2019 · 12 citations